Recherche
Voies oncogéniques dans le cancer du poumon : A. Maraver

Liste des Publications

Bianco J, Bergoglio V, Lin Y-L, Pillaire M-J, Schmitz A-L, Gilhodes J, Lusque A, Mazières J, Lacroix-Triki M, Roumeliotis T, Choudhary J, Moreaux J, Hoffmann J-S, Tourrière H, Pasero P Overexpression of Claspin and Timeless protects cancer cells from replication stress in a checkpoint-independent manner. Nat Commun. 2019;10(1):910. doi:10.1038/s41467-019-08886-8

Paul C, Delpech H, Haouzi D, Hamamah S, Sardet C, Fabbrizio E Coprs inactivation leads to a derepression of LINE1 transposons in spermatocytes. FEBS Open Bio. 2019;9(1):159-168. doi:10.1002/2211-5463.12562

Pujol J-L, Jean-Baptiste S, Bommart S, Roch B Synchronous multiple non-small cell lung cancers in an allograft lung recipient. Lung Cancer. 2018;124. doi:10.1016/j.lungcan.2018.07.024

Pujol J-L, Roch B, Roth C, Mérel J-P Qualitative study of patients' decision-making when accepting second-line treatment after failure of first-line chemotherapy. PLoS ONE. 2018;13(5):e0197605. doi:10.1371/journal.pone.0197605

Antonia S, Villegas A, Daniel D, Vicente D, Murakami S, Hui R, Kurata T, Chiappori A, Lee K, de Wit M, Cho B, Bourhaba M, Quantin X, Tokito T, Mekhail T, Planchard D, Kim Y-C, Karapetis C, Hiret S, Ostoros G, Kubota K, Gray J, Paz-Ares L, de Castro Carpeño J, Faivre-Finn C, Reck M, Vansteenkiste J, Spigel D, Wadsworth C, Melillo G, Taboada M, Dennis P, Özgüro?lu M Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC. N. Engl. J. Med.. Sep 25, 2018. doi:10.1056/NEJMoa1809697

Hamann H, Pujol J-L Introduction to the Special Section: The Experience and Impact of Lung Cancer Stigma. J Thorac Oncol. 2018;13(8):1053-1054. doi:10.1016/j.jtho.2018.06.006

Middleton G, Gridelli C, Pujol J-L, Reck M, Ramlau R, Parente B, Pieters T, Visseren-Grul C, John W, Zimmermann A, Chouaki N, Paz-Ares L Evaluation of changes in renal function in PARAMOUNT: a phase III study of maintenance pemetrexed plus best supportive care versus placebo plus best supportive care after induction treatment with pemetrexed plus cisplatin for advanced nonsquamous non-small-cell lung cancer. Curr Med Res Opin. 2018;34(5):865-871. doi:10.1080/03007995.2018.1439462

Solassol J, Quantin X, Larrieux M, Senal R, Audran P, Grand D, Mangé A, Diamandis E, Vendrell J Comparison of five cell-free DNA isolation methods to detect the EGFR T790M mutation in plasma samples of patients with lung cancer. Clin. Chem. Lab. Med.. 2018;56(9):e243-e246. doi:10.1515/cclm-2017-0967

Sanclemente M, Francoz S, Esteban-Burgos L, Bousquet-Mur E, Djurec M, Lopez-Casas P, Hidalgo M, Guerra C, Drosten M, Musteanu M, Barbacid M c-RAF Ablation Induces Regression of Advanced Kras/Trp53 Mutant Lung Adenocarcinomas by a Mechanism Independent of MAPK Signaling. Cancer Cell. 2018;33(2):217-228.e4. doi:10.1016/j.ccell.2017.12.014

Mancini M, Gaborit N, Mazzeo L, Romaniello D, Salame T, Lindzen M, Mahlknecht G, Enuka Y, Burton D, Roth L, Noronha A, Marrocco I, Adreka D, Altstadter R, Bousquet E, Downward J, Maraver A, Krizhanovsky V, Yarden Y An oligoclonal antibody durably overcomes resistance of lung cancer to third-generation EGFR inhibitors. EMBO Mol Med. 2018;10(2):294-308. doi:10.15252/emmm.201708076

Romaniello D, Mazzeo L, Mancini M, Marrocco I, Noronha A, Kreitman M, Srivastava S, Ghosh S, Lindzen M, Salame T, Onn A, Bar J, Yarden Y A Combination of Approved Antibodies Overcomes Resistance of Lung Cancer to Osimertinib by Blocking Bypass Pathways. Clin. Cancer Res.. Jul 02, 2018. doi:10.1158/1078-0432.CCR-18-0450

Calvayrac O, Mazières J, Figarol S, Marty-Detraves C, Raymond-Letron I, Bousquet E, Farella M, Clermont-Taranchon E, Milia J, Rouquette I, Guibert N, Cadranel J, Mathiot N, Savina A, Pradines A, Favre G The RAS-related GTPase RHOB confers resistance to EGFR-tyrosine kinase inhibitors in non-small-cell lung cancer via an AKT-dependent mechanism. EMBO Mol Med. 2017;9(2):238-250. doi:10.15252/emmm.201606646

Chebli K, Papon L, Paul C, Garcel A, Campos N, Scherrer D, J Ehrlich H, Hahne M, Tazi J The Anti-Hiv Candidate Abx464 Dampens Intestinal Inflammation by Triggering Il-22 Production in Activated Macrophages. Sci Rep. 2017;7(1):4860. doi:10.1038/s41598-017-04071-3

Langer C, Paz-Ares L, Wozniak A, Gridelli C, de Marinis F, Pujol J-L, San Antonio B, Chen J, Liu J, Oton A, Visseren-Grul C, Scagliotti G Safety Analyses of Pemetrexed-cisplatin and Pemetrexed Maintenance Therapies in Patients With Advanced Non-squamous NSCLC: Retrospective Analyses From 2 Phase III Studies. Clin Lung Cancer. 2017;18(5):489-496. doi:10.1016/j.cllc.2017.04.003

Basse C, Thureau S, Bota S, Dansin E, Thomas P-A, Pichon E, Lena H, Massabeau C, Clément-Duchene C, Massard G, Westeel V, Quantin X, Oulkhouir Y, Danhier S, Lerouge D, Tanguy R, Thillays F, Le Pechoux C, Dubray B, Thiberville L, Besse B, Girard N Multidisciplinary Tumor Board Decision Making for Postoperative Radiotherapy in Thymic Epithelial Tumors: Insights from the RYTHMIC Prospective Cohort. J Thorac Oncol. 2017;12(11):1715-1722. doi:10.1016/j.jtho.2017.07.023

Bommart S, Berthet J, Durand G, Pujol J, Mathieu C, Marty-Ané C, Kovacsik H Imaging of postoperative complications following surgery for lung cancer. Diagn Interv Imaging. 2017;98(1):11-20. doi:10.1016/j.diii.2015.06.022

Antonia S, Villegas A, Daniel D, Vicente D, Murakami S, Hui R, Yokoi T, Chiappori A, Lee K, de Wit M, Cho B, Bourhaba M, Quantin X, Tokito T, Mekhail T, Planchard D, Kim Y-C, Karapetis C, Hiret S, Ostoros G, Kubota K, Gray J, Paz-Ares L, de Castro Carpeño J, Wadsworth C, Melillo G, Jiang H, Huang Y, Dennis P, Özgüro?lu M Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer. N. Engl. J. Med.. 2017;377(20):1919-1929. doi:10.1056/NEJMoa1709937

Vendrell J, Taviaux S, Béganton B, Godreuil S, Audran P, Grand D, Clermont E, Serre I, Szablewski V, Coopman P, Mazières J, Costes V, Pujol J-L, Brousset P, Rouquette I, Solassol J Detection of known and novel ALK fusion transcripts in lung cancer patients using next-generation sequencing approaches. Sci Rep. 2017;7(1):12510. doi:10.1038/s41598-017-12679-8

Casas-Tintó S, Maraver A, Serrano M, Ferrús A Troponin-I enhances and is required for oncogenic overgrowth. Oncotarget. 2016;7(33):52631-52642. doi:10.18632/oncotarget.10616

Pujol J, De Pas T, Rittmeyer A, Vallieres E, Kubisa B, Levchenko E, Wiesemann S, Masters G, Shen R, Tjulandin S, Hofmann H, Vanhoutte N, Salaun B, Debois M, Jarnjak S, De Sousa Alves P, Louahed J, Brichard V, Lehmann F Safety and immunogenicity of the PRAME cancer immunotherapeutic in patients with resected non-small cell lung cancer: a phase I dose escalation study. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. Aug 17 2016. doi:10.1016/j.jtho.2016.08.120

Barlesi F, Mazieres J, Merlio J, Debieuvre D, Mosser J, Lena H, Ouafik L, Besse B, Rouquette I, Westeel V, Escande F, Monnet I, Lemoine A, Veillon R, Blons H, Audigier-Valette C, Bringuier P, Lamy R, Beau-Faller M, Pujol J, Sabourin J, Penault-Llorca F, Denis M, Lantuejoul S, Morin F, Tran Q, Missy P, Langlais A, Milleron B, Cadranel J, Soria J, Zalcman G, Biomarkers France c Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT). Lancet. Jan 14 2016. doi:10.1016/S0140-6736(16)00004-0

Levallet G, Dubois F, Fouret P, Antoine M, Brosseau S, Bergot E, Beau-Faller M, Gounant V, Brambilla E, Debieuvre D, Molinier O, Galateau-Salle F, Mazieres J, Quoix E, Pujol J, Moro-Sibilot D, Langlais A, Morin F, Westeel V, Zalcman G MSH2/BRCA1 expression as a DNA-repair signature predicting survival in early-stage lung cancer patients from the IFCT-0002 Phase 3 Trial. Oncotarget. Dec 19 2016. doi:10.18632/oncotarget.14025

Pujol J Is Weight Loss a Loss of Chance in Patients Receiving Chemoradiotherapy?. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2016;11. doi:10.1016/j.jtho.2016.04.010

Makinson A, Eymard-Duvernay S, Raffi F, Abgrall S, Bommart S, Zucman D, Valour F, Cheret A, Poizot-Martin I, Duvivier C, Mauboussin J, Bonnet F, Tattevin P, Reynes J, Le Moing V, Anrs Ep Hiv Chest study Team Feasibility and efficacy of early lung cancer diagnosis with chest computed tomography in HIV-infected smokers. Aids. 2016;30. doi:10.1097/QAD.0000000000000943

Rivera-Torres J, Guzman-Martinez G, Villa-Bellosta R, Orbe J, Gonzalez-Gomez C, Serrano M, Diez J, Andres V, Maraver A Targeting gamma-secretases protect against angiotensin II-induced cardiac hypertrophy. Journal of hypertension. 2015;33. doi:10.1097/HJH.0000000000000463



© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés